Project Masihambisane: a cluster randomised controlled trial with peer mentors to improve outcomes for pregnant mothers living with HIV

Trials. 2011 Jan 4;12:2. doi: 10.1186/1745-6215-12-2.


Background: Pregnant women living with HIV (WLH) face daily challenges maintaining their own and their babies' health and mental health. Standard Prevention of Maternal to Child Transmission (PMTCT) programs are not designed to address these challenges.

Methods/design: As part of a cluster randomized controlled trial, WLH are invited to attend four antenatal and four postnatal small group sessions led by a peer WLH (a Peer Mentor). The WLH and their babies are assessed during pregnancy and at one week, six months, and twelve months post-birth. Mobile phones are used to collect routine information, complete questionnaires and remain in contact with participants over time. Pregnant WLH (N = 1200) are randomly assigned by clinic (N = 8 clinics) to an intervention program, called Masihambisane (n = 4 clinics, n = 600 WLH) or a standard care PMTCT control condition (n = 4 clinics; n = 600 WLH).

Discussion: Data collection with cellular phones are innovative and effective in low-resource settings. Standard PMTCT programs are not designed to address the daily challenges faced by WLH; Peer Mentors may be useful in supporting WLH to cope with these challenges.

Trial registration: registration # NCT00972699.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adaptation, Psychological
  • Anti-HIV Agents / therapeutic use
  • Cell Phone
  • Cluster Analysis
  • Female
  • Group Processes*
  • HIV Infections / psychology
  • HIV Infections / therapy*
  • HIV Infections / transmission
  • Health Behavior*
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Infant
  • Infant, Newborn
  • Maternal Health Services*
  • Mentors*
  • Patient Compliance
  • Peer Group*
  • Postnatal Care
  • Pregnancy
  • Pregnancy Complications, Infectious / psychology
  • Pregnancy Complications, Infectious / therapy*
  • Prenatal Care
  • Research Design*
  • Risk Reduction Behavior
  • South Africa
  • Surveys and Questionnaires
  • Time Factors
  • Treatment Outcome


  • Anti-HIV Agents

Associated data